Revised Dose Ramp-Up to Mitigate the Risk of Tumor Lysis Syndrome When Initiating Venetoclax in Patients With Mantle Cell LymphomaMatthew S. Davids, Constantine S. Tam, Andrew W. Roberts et al.|Journal of Clinical Oncology|2018Cited by 28